ACT-CHIK, a project led by Institut Pasteur, will advance chikungunya vaccine trials across four African countries.
Funded by the Global Health EDCTP3 Joint Undertaking, a new €15.3 million project coordinated by Institut Pasteur brings together seven partners across four continents to advance clinical trials and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results